World · India Bureau
GLP-1 drugs offer weight loss but carry serious side effect risks
While semaglutide and similar GLP-1 medications have gained popularity for weight management, medical experts warn users should be aware of both common and potentially severe adverse effects. Digestive complications and rare but serious complications can occur alongside the promised weight loss benefits.
LSN India ·
GLP-1 receptor agonists, including the widely-used semaglutide, have revolutionized weight loss treatment and attracted millions of users seeking to shed excess kilograms. However, health authorities and medical professionals emphasize that these medications carry a spectrum of side effects that patients must understand before beginning treatment.
Common adverse effects include nausea, vomiting, diarrhea, and constipation—primarily affecting the digestive system as the body adjusts to the medication. Most users experience these temporary symptoms during initial treatment phases, which typically subside as tolerance develops. Nevertheless, gastrointestinal disturbances can persist in some cases and significantly impact quality of life.
Beyond routine digestive issues, medical literature documents less frequent but more serious complications. These include pancreatitis, gallbladder problems, and thyroid-related concerns. Healthcare providers stress the importance of medical supervision and recommend that patients with personal or family histories of certain conditions exercise caution or avoid these medications entirely.
Experts advise prospective users to consult qualified healthcare practitioners before starting GLP-1 therapy, particularly those with existing medical conditions. Monitoring during treatment remains essential to identify and manage any emerging complications early. As these medications continue gaining popularity across South Asia, informed decision-making becomes critical for ensuring safe and appropriate use.